ADPGK and neoplasm: This tumor vaccine promotes Adpgk/CpG presentation to APCs, activates broad-spectrum T cell responses, and eradicates tumors in combination with ICI, and neoantigen Adpgk-based nanodiscs also produce significant immune responses in mouse models [129].